Landscapes / Companies
Kunming Pharmaceuticals, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
2 in Phase 1
Drugs
4
in active trials · 5 in all
Trials
4 active
6 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Sep 2028Phase 2 trial completes | |||
| Next date | 30 Sep 2028 · Phase 2 trial completes | ||||
| Also tested for | Discoid Lupus Erythematosus | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Acute Ischemic Stroke | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Delirium | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Open drug page | |||||
About
- No active trial
- KY100001
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021